OPEN END TURBO LONG - TALANX Stock

Certificat

DE000MD7LTF1

Market Closed - Börse Stuttgart 12:36:49 2024-07-05 EDT
3.67 EUR -1.87% Intraday chart for OPEN END TURBO LONG - TALANX
Current month-8.48%
1 month-9.38%
Date Price Change
24-07-05 3.67 -1.87%
24-07-04 3.74 +1.08%
24-07-03 3.7 -1.07%
24-07-02 3.74 -8.56%
24-07-01 4.09 +2.00%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 12:36 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying TALANX AG
Issuer Morgan Stanley
WKN MD7LTF
ISINDE000MD7LTF1
Date issued 2022-08-30
Strike 34.27
Maturity Unlimited
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.14
Lowest since issue 0.196

Company Profile

Talanx AG (Talanx) is a Germany-based provider of insurance and reinsurance products and services. The Company's activities are divided into five segments: Retail Germany, Retail International, Industrial Lines, Non-Life Reinsurance, and Life/Health Reinsurance. The Retail Germany segment is operated by the subsidiary Talanx Deutschland AG and manages insurance activities serving German retail and commercial customers; the Retail International segment is managed by Talanx International AG and encompasses insurance activities outside of Germany; the Industrial Lines segment is operated by HDI Global SE, which delivers insurance solutions to retail customers and industrial clients, and the reinsurance business, including the Non-Life Reinsurance and the Life/Health Reinsurance segments, is handled by Hannover Rueck SE. The Company markets its products, among others, through the Warta, Europa, Posta Biztosito and CiV Life brands. It is a majority-owned subsidiary of HDI VaG.
Sector
-
More about the company

Ratings for Talanx AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Talanx AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
70.95 EUR
Average target price
69.67 EUR
Spread / Average Target
-1.80%
Consensus